Ranbaxy loses generic exclusivity over $6 billion Nexium market
dna - January 28, 2015
Drugmaker Ranbaxy on Tuesday said that the US Food and Drug Administration (FDA) has determined that the Indian drug manufacturer has forfeited its 180-day exclusivity to sell generic version of AstraZeneca Plc's heartburn drug Nexium in the US market.
House Republicans propose changes for NIH, FDA
The Baltimore Sun - January 28, 2015
House Republicans are considering significant changes to the way billions of dollars in National Institutes of Health grants are awarded to research institutions under a proposal intended to speed medical breakthroughs.
Supreme Court Sides With Teva in Drug Dispute
Associated Press - January 20, 2015
The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.
High Prices for Cancer Drugs are set at Launch: ‘It’s Where the Action Is’
Wall Street Journal - January 21, 2015
There is little question that rising prices for medicines – including many cancer treatments – is a flashpoint in the growing controversy over health care costs. But just how much have the prices for new cancer drugs been rising in recent years?
Merck stops production of HCV drug due to low demand
Drug Topics - January 22, 2015
Merck is voluntarily discontinuing the production and distribution of the hepatitis C virus therapy boceprevir (Victrelis) by December 2015 because of low demand. The company recommends to prescribers that new patients not be started on this therapy.
Prices for Prescription Medicines Rose How Much Last Year?
Wall Street Journal - January 26, 2015
The prices of prescription medicines is a front-and-center issue as the cost to treat everything from some of the rarest diseases to the most common afflictions is causing increasing concern among payers, physicians and consumers. But how much exactly did prices rise last year?
Antibiotics for Traveler's Diarrhea May Spur Growth of Superbugs: Study
HealthDay News - January 22, 2015
Researchers recommend caution when using antibiotics to treat digestive ills while abroad.
NIH study reveals many Americans at risk for alcohol-medication interactions
National Institutes of Health - January 16, 2015
Nearly 42 percent of U.S. adults who drink also report using medications known to interact with alcohol, based on a study from the National Institutes of Health released today.
House reintroduces legislation to thwart drug diversion
Drug Store News - January 22, 2015
Four House representatives on Thursday reintroduced legislation designed to help prevent prescription drug abuse and diversion and ensure patient access to necessary medications by creating a more collaborative partnership between drug manufacturers, wholesalers, retail pharmacies and federal enforcement and oversight agencies.
Is High-Intensity Statin Therapy Underused?
American College of Cardiology - January 19, 2015
The majority of patients do not fill high-intensity statin prescriptions following a hospitalization for a coronary heart disease event, according to a study published Jan. 19 in the Journal of the American College of Cardiology.
Over-the-counter sleep aids linked to dementia
Medical News Today - January 27, 2015
A new study has found a significant link between high use of anticholinergic drugs - including popular non-prescription sleep aids and the antihistamine Benadryl (diphenhydramine) - and increased risk of developing dementia and Alzheimer's disease in older people.
Cooperation between cancer cells makes therapies ineffective, suggests new treatment
ScienceDaily - January 26, 2015
New research shows why many cancers are difficult to treat and come back following treatment.
1,700 Hospitals Win Quality Bonuses From Medicare, But Most Will Never Collect
Kaiser Health News - January 22, 2015
Medicare is giving bonuses to a majority of hospitals that it graded on quality, but many of those rewards will be wiped out by penalties the government has issued for other shortcomings, federal data show.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |